Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation-Reference-Cited by-同舟云学术

Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation

Published:2009-07-07 Issue:2 Volume:89 Page:141-146
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

De Stefano Valerio, ,Za Tommaso,Rossi Elena,Vannucchi Alessandro M.,Ruggeri Marco,Elli Elena,Micò Caterina,Tieghi Alessia,Cacciola Rossella R.,Santoro Cristina,Vianelli Nicola,Guglielmelli Paola,Pieri Lisa,Scognamiglio Francesca,Cacciola Emma,Rodeghiero Francesco,Pogliani Enrico M.,Finazzi Guido,Gugliotta Luigi,Leone Giuseppe,Barbui Tiziano

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-009-0788-5.pdf

Reference19 articles.

1. Elliott MA, Tefferi A (2005) Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 128:275–290

2. Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556–562

3. Besses C, Cervantes F, Pereira A, Florensa L, Sole F, Hernandez-Boluda JC, Woessner S, Sans-Sabrafen J, Rozman C, Montserrat E (1999) Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia 13:150–154

4. Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, Orlandi E, Arcaini L, Brusamolino E, Pascutto C, Cazzola M, Morra E, Lazzarino M (2004) Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med 117:755–761

5. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A (2006) Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 81:159–166

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of acute coronary syndrome in patients with myeloproliferative neoplasms;Frontiers in Cardiovascular Medicine;2024-06-25

2. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03

3. Molecular genetics of thrombotic myeloproliferative neoplasms: Implications in precision oncology;Genes & Diseases;2021-01

4. The role of driver mutations in myeloproliferative neoplasms: insights from mouse models;International Journal of Hematology;2019-12-21

5. Therapeutic Apheresis—Applications for Hemorrhagic and Thrombotic Disorders;Consultative Hemostasis and Thrombosis;2019